OBI 2
Alternative Names: OB-2Latest Information Update: 22 Jan 2010
At a glance
- Originator Ipsen
- Class Blood coagulation factors; Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia A
Most Recent Events
- 15 Jul 2003 Preclinical trials in Haemophilia A in France (unspecified route)